Settlement guide

What Could a Hair Relaxer Claim Pay?

A future test trial is not a payout offer. Ask a lawyer about your own claim and the source of any amount.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202611 sources

This may apply to you if

  • List the chemical relaxer or straightener brands you used and your best use dates.
  • Have the report that names your cancer and the diagnosis date ready to discuss.
  • Ask a lawyer to check the product history, claim rules and filing time. The study’s use categories are not a claim cutoff.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Mary M. Rowland · U.S. District Court, Northern District of Illinois · United States District Judge

Finding: The September 24, 2026 court notice schedules the first federal test trial for September 7, 2027. A scheduled test trial is not a payment date or a ruling that every claim succeeds.

Notification of docket entry, Document 2041 (opens in a new tab) · Sep 24, 2026 · Checked Oct 3, 2026

Che-Jung Chang · National Institute of Environmental Health Sciences, Epidemiology Branch · First-listed study author

Finding: The Sister Study analysis found an association between reported straightening-product use and later uterine cancer. The authors call for more research; the finding does not prove a product caused one person’s cancer.

Use of Straighteners and Other Hair Products and Incident Uterine Cancer (opens in a new tab) · Dec 8, 2022 · Checked Oct 3, 2026

The evidence and its limits

National Institute of Environmental Health Sciences · Journal of the National Cancer Institute · 2022

Sister Study analysis of hair products and uterine cancer

Design:
Cohort
Participants:
33,947 women aged 35–74 with a uterus at enrollment
Finding:
Reported straightening-product use was associated with later uterine cancer; the association was stronger in the study’s frequent-use group.
Main limitation
Observational data and self-reported use in the prior year; the authors call for replication and identifying the chemicals involved. It does not prove that a particular product caused one person’s illness.

Read the source: Sister Study analysis of hair products and uterine cancer (opens in a new tab) · Checked Oct 3, 2026

The short answer

Has a settlement been announced in the notice?
The court notice we checked sets a test trial. It gives no deal or payment grid. Ask a lawyer to check later orders and your own claim. [1]
What do we know about individual amounts?
The notice does not set a payment for you. Ask where a quoted amount came from and whose case it covers. [1]
What factors would a lawyer check for my claim?
Your product, diagnosis, dates and losses need review. Allegations and study findings do not decide the value of your case. [2]
What fees or costs could reduce an award?
Ask the firm for written fee and expense terms. Ask what you could owe after a loss and what deductions could apply to any recovery. [5]

What rules a case out

Not covered by this case

  • A test-trial date is not a payment date.
  • One court notice does not reveal every private agreement.
  • Research risk figures do not measure legal damages.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

No settlement announced · Bellwether trials

No settlement has been announced in the Hair relaxer cancer litigation.

Test trials are under way. Anyone quoting a payout figure today is guessing.

Source: llamalab.ai · as of Jul 1, 2026

A future test trial is not a payout offer. Ask a lawyer about your own claim and the source of any amount. This guide cannot estimate what you would receive.

Has a settlement been announced in the notice?

The court notice we checked sets a test trial. It gives no deal or payment grid. Ask a lawyer to check later orders and your own claim.

The September 24, 2026 court notice sets the first test trial for September 7, 2027. It also schedules case-management dates. Those are court-work dates, not a program offering money to each person who used a relaxer.

What do we know about individual amounts?

The notice does not set a payment for you. Ask where a quoted amount came from and whose case it covers.

The reviewed one-page notice cannot establish an award range or an individual payment formula. An ad, a different lawsuit or a research risk number is not your offer. Request the actual document behind any figure.

What factors would a lawyer check for my claim?

Your product, diagnosis, dates and losses need review. Allegations and study findings do not decide the value of your case.

The transfer order describes allegations of reproductive harm. It does not find that every product caused every illness. Ask which evidence supports your proposed claim and which losses the applicable law allows.

If you have a lawyer already, ask that firm about your case status before treating another website as a new offer. A research use group is not a payment tier or universal acceptance rule.

What fees or costs could reduce an award?

Ask the firm for written fee and expense terms. Ask what you could owe after a loss and what deductions could apply to any recovery.

The ABA model rule discusses outcome-based fee calculation and case expenses. It is not a state-specific contract or this firm’s verified price. Have the lawyer explain the gross amount, fees, costs and proposed amount you keep.

When could a payment arrive?

The future trial date does not promise a payment. Ask the lawyer handling your case about its next step and any payment terms.

A scheduled test trial could inform the wider cases, but it does not resolve your claim by itself. The notice does not supply a personal payment date. Check the current docket and your case through counsel.

Should I trust an online payout number?

Treat the number as a claim to verify. Ask for its source and whether it applies to you. Do not budget as though an advertised amount is your offer.

The uterine study concerns disease associations, not claim payments. A percentage from that research cannot be converted into legal damages. The study also does not name the product brands each participant used.

What happens if I ask for a check?

Bring the product and diagnosis records you have. Ask who handles the claim, which deadline applies and what the agreement requires.

Access to covered health records generally has a federal route, with exceptions. Ask the provider about missing reports. Your legal filing deadline depends on the claim and law; do not substitute the court’s management dates.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Ask a law firm to review your case

Questions about this guide

What happens if the Daubert hearing goes badly for plaintiffs?

If the court excluded plaintiffs' general causation experts, the cases could face serious challenges. The court's September 24, 2026 notice sets the first federal test trial for September 7, 2027, with monthly court conferences before it. No one can predict how the court will rule on expert evidence or how a trial will come out.

Should I file now or wait for bellwether results?

Questions about time limits can be asked before test-trial results are known. The time limit is set by the law and type of claim, not by the MDL calendar. Whether that time has passed depends on your facts, so don't rule yourself out. A lawyer can tell you. The first federal test trial is set for September 7, 2027, and its result will not set what any other claim is worth.

How are individual settlement amounts calculated in an MDL?

No one has announced a settlement program, point system or payment grid for hair relaxer claims. Programs in other MDLs have weighed factors such as injury type and severity, age at diagnosis, product use and medical costs, but any program would set its own terms. No settlement has been announced. What any claim is worth depends on its facts, and no one can promise an amount.

Sources

  1. Court docket notice 2041, September 24, 2026 (primary court-document mirror)Court docket notice 2041, September 24, 2026 (primary court-document mirror) · court
  2. JPML transfer order, February 6, 2023JPML transfer order, February 6, 2023 · court
  3. Chang et al.: original study abstract, 2022Chang et al.: original study abstract, 2022 · study
  4. JPML pending actions report, October 1, 2026 (cached primary PDF)JPML pending actions report, October 1, 2026 (cached primary PDF) · court
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. Court guide: filing time limitsCourt guide: filing time limits · court
  7. Health-record access, 45 CFR 164.524Health-record access, 45 CFR 164.524 · regulator
  8. JNCI 2022 original author abstract via PubMedNational Library of Medicine · study
  9. Hair Relaxer Use and Risk of Uterine Cancer in the Black Women's Health StudyEnvironmental Research · 2023 · study
  10. Use of Hair Products in Relation to Ovarian Cancer RiskCarcinogenesis · 2021 · study
  11. Scheduling posture in MDL-3060 (N.D. Ill., Judge Mary Rowland): the court took direct control of bellwether selection (April 2026), scrapping the party alternating-picks system; bellwether fact discovery closed June 10, 2026; case-specific Daubert and summary judgment motions due Nov 16, 2026; first trials broadly expected 2027. 11,877 cases pending as of July 1, 2026 (fourth-largest MDL). No verdicts or settlements yet. CAVEAT: documented only via litigation-tracker blogs (llamalab.ai, mdlupdate.com) — last-resort sources, no court record or major-press confirmation fetched.llamalab.ai · Jul 1, 2026 · court

Checked against 10 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026